Agilent Technologies, Inc. $A Shares Sold by Shell Asset Management Co.

Shell Asset Management Co. decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 75.3% during the third quarter, Holdings Channel.com reports. The fund owned 5,132 shares of the medical research company’s stock after selling 15,640 shares during the period. Shell Asset Management Co.’s holdings in Agilent Technologies were worth $659,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Resona Asset Management Co. Ltd. grew its stake in shares of Agilent Technologies by 6.2% during the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock worth $11,631,000 after purchasing an additional 5,767 shares during the period. CCLA Investment Management boosted its holdings in Agilent Technologies by 10.5% during the third quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock worth $131,909,000 after buying an additional 97,312 shares in the last quarter. Nuance Investments LLC grew its position in Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock valued at $9,523,000 after buying an additional 9,628 shares during the period. Osaic Holdings Inc. grew its position in Agilent Technologies by 35.5% during the second quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock valued at $8,017,000 after buying an additional 17,817 shares during the period. Finally, Fenimore Asset Management Inc increased its holdings in Agilent Technologies by 224.2% in the third quarter. Fenimore Asset Management Inc now owns 586,500 shares of the medical research company’s stock valued at $75,277,000 after buying an additional 405,620 shares in the last quarter.

Insider Buying and Selling at Agilent Technologies

In other news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Agilent Technologies Trading Up 0.7%

Shares of A stock opened at $125.80 on Tuesday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The stock’s fifty day moving average is $137.51 and its two-hundred day moving average is $135.61. The firm has a market capitalization of $35.58 billion, a P/E ratio of 27.53, a PEG ratio of 3.65 and a beta of 1.30.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Research analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is 22.32%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Robert W. Baird boosted their price objective on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, November 25th. Citigroup upped their target price on Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. Morgan Stanley assumed coverage on Agilent Technologies in a research report on Tuesday, December 2nd. They set an “overweight” rating on the stock. Finally, Barclays raised shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price target for the company in a report on Monday, December 15th. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $164.50.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.